MedDRA
MedDRA (Medical Dictionary for Regulatory Activities) is a standardized medical terminology used internationally for the classification of adverse event information associated with the use of medical products. It is maintained and developed by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).
Overview[edit]
MedDRA is a rich and highly specific terminology that facilitates the standardization of regulatory communication and the exchange of data between regulatory authorities, pharmaceutical companies, and other stakeholders in the healthcare industry. It provides a structured and comprehensive way to encode medical concepts related to adverse events, medical history, and drug indications.
Structure[edit]
MedDRA is organized into five hierarchical levels: System Organ Classes (SOCs), High-Level Group Terms (HLGTs), High-Level Terms (HLTs), Preferred Terms (PTs), and Lowest Level Terms (LLTs). Each term in MedDRA is assigned a unique code, allowing for precise identification and classification of medical concepts.
Application[edit]
MedDRA is used in various aspects of pharmacovigilance, clinical research, and regulatory activities. It is employed in the coding and analysis of adverse event data in clinical trials, post-marketing surveillance, and regulatory submissions. By using a standardized terminology like MedDRA, stakeholders can ensure consistency and comparability in adverse event reporting and analysis.
Advantages[edit]
The use of MedDRA offers several advantages, including improved data quality, enhanced signal detection, and increased efficiency in regulatory processes. Its hierarchical structure allows for detailed coding of medical concepts while maintaining flexibility for data analysis and reporting.
Limitations[edit]
While MedDRA is a valuable tool for standardizing medical terminology, it is important to note that the terminology may not cover every possible medical concept or scenario. Users should be aware of the limitations of MedDRA and exercise caution when interpreting and analyzing data coded using this terminology.
Future Developments[edit]
The ICH periodically updates and maintains MedDRA to ensure its relevance and accuracy in the ever-evolving field of healthcare. Future developments may include the addition of new terms, refinement of existing concepts, and enhancements to the usability and functionality of the terminology.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian